Phase 2, dose-ranging study of vupanorsen in patients with diabetes, steatosis and hypertriglyceridaemia (NCT03371355)
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.